Alyeska Investment Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-750,412
| Closed | -$2.66M | – | 551 |
|
|
2025
Q1 | $2.66M | Sell |
750,412
-73,008
| -9% | -$258K | 0.01% | 400 |
|
|
2024
Q4 | $3.11M | Sell |
823,420
-1,200,000
| -59% | -$4.54M | 0.01% | 437 |
|
|
2024
Q3 | $6.56M | Buy |
2,023,420
+200,000
| +11% | +$648K | 0.03% | 327 |
|
|
2024
Q2 | $3.46M | Buy |
1,823,420
+814,813
| +81% | +$1.55M | 0.02% | 361 |
|
|
2024
Q1 | $2.86M | Buy |
+1,008,607
| New | +$2.86M | 0.02% | 349 |
|
|
2023
Q4 | – | Sell |
-120,157
| Closed | -$2.2M | – | 434 |
|
|
2023
Q3 | $2.2M | Sell |
120,157
-200,000
| -62% | -$3.66M | 0.01% | 371 |
|
|
2023
Q2 | $6.91M | Buy |
320,157
+68,750
| +27% | +$1.48M | 0.05% | 295 |
|
|
2023
Q1 | $7.38M | Buy |
251,407
+201,407
| +403% | +$5.91M | 0.06% | 269 |
|
|
2022
Q4 | $1.85M | Buy |
+50,000
| New | +$1.85M | 0.02% | 326 |
|